Ministry of Health and Welfare. Cancer registration statistics, Health section, 2017. Daejeon: National Statistical Office; 2017 Dec. 95 p.
Park SY, Lee JG, Kim J, Park Y, Lee SK, Bae MK, et al. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung. Lung Cancer 2013 ;79: 156-60.
Stieber P, Bodenmüller H, Banauch D, Hasholzner U, Dessauer A, OfenlochHähnle B, et al. Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer. Clin Biochem 1993; 26: 301-4.
Edelman MJ, Hodgson L, Rosenblatt PY, Christenson RH, Vokes EE, Wang X, et al. CYFRA 21-1 as a prognostic and predictive marker in advanced non-smal-cell lung cancer in a prospective trial: CALGB 150304. J Thorac Oncol 2012; 7: 649-54.
Lee S, Lee CY, Kim DJ, Hong DJ, Lee JG, Chung KY. Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer. Korean J Thorac Cardiovasc Surg 2013; 46:192-6.
Ono A, Takahashi T, Mori K, Akamatsu H, Shukuya T, Taira T, et al. Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma:a retrospective study. BMC Cancer 2013; 13: 354.
Chen Q, Ge F, Cui W, Wang F, Yang Z, Guo Y, et al. Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with cytokeratin 19-derived CYFRA21-1 and pathological staging. Clin Chim Acta 2013; 419: 57-61.
Park HD, Jeong HS, Park JS, Lim SH, Lee EJ, Yun JW, et al. Usefulness of cyfra 21-1 as a tumor marker of lung cancer. Korean J Med 2002; 62: 415-21.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
Niklinski J, Furman M, Rapellino M, Chyczewski L, Laudanski J, Oliaro A, et al. CYFRA 21-1 determination in patients with non-small cell lung cancer:clinical utility for the detection of recurrences. J Cardiovasc Surg (Torino) 1995; 36: 501-4.
Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53: 61-6.
Jung M, Kim SH, Hong S, Kang YA, Kim SK, Chang J, et al. Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J 2012; 53: 931-9.
Yoon HD, Kim KD, Chung JH, Lee HW, Lee KH, Lee HW, et al. Diagnostic value of serum CYFRA 21-1 in lung cancer. Tuberc Respir Dis 1995; 42:149-55.